Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Cellectis	Inhibrx	Krystal Biotech	Adverum Biotechnologies	Aligos Therapeutics
Symbol	NASDAQ:CLLS	NASDAQ:INBX	NASDAQ:KRYS	NASDAQ:ADVM	NASDAQ:ALGS
Price Information
Current Price	$22.16	$29.75	$84.27	$12.15	$24.78
52 Week Range	Hold	Buy	Buy	Buy	Buy
MarketRank™
Overall Score	0.8	1.5	1.3	1.7	1.3
Analysis Score	1.2	2.5	2.5	3.4	2.5
Community Score	2.9	3.3	2.5	2.4	3.3
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	0.8	1.7	2.5	0.0
Earnings & Valuation Score	0.0	0.6	0.0	0.0	0.6
Analyst Ratings
Consensus Recommendation	Hold	Buy	Buy	Buy	Buy
Consensus Price Target	$24.25	$34.67	$101.00	$23.50	$30.50
% Upside from Price Target	9.43% upside	16.53% upside	19.85% upside	93.42% upside	23.08% upside
Trade Information
Market Cap	$941.49 million	$1.12 billion	$1.66 billion	$1.18 billion	$944.56 million
Beta	2.59	N/A	1.2	1.72	N/A
Average Volume	443,501	174,114	169,911	837,306	81,043
Sales & Book Value
Annual Revenue	$22.99 million	N/A	N/A	$250,000.00	N/A
Price / Sales	40.95	N/A	N/A	4,737.43	N/A
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$8.37 per share	N/A	$11.72 per share	$2.71 per share	N/A
Price / Book	2.65	N/A	N/A	4.48	N/A
Profitability
Net Income	$-102,090,000.00	N/A	$-19,090,000.00	$-64,490,000.00	N/A
EPS	($2.41)	N/A	($1.20)	($1.01)	N/A
Trailing P/E Ratio	N/A	0.00	N/A	N/A	0.00
Forward P/E Ratio	N/A	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-110.52%	N/A	N/A	N/A	N/A
Return on Equity (ROE)	-23.56%	N/A	-10.72%	-32.23%	N/A
Return on Assets (ROA)	-16.69%	N/A	-10.40%	-28.02%	N/A
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.10%	0.18%	N/A	N/A	N/A
Current Ratio	6.11%	3.80%	39.96%	28.53%	N/A
Quick Ratio	6.00%	3.80%	39.96%	28.53%	N/A
Ownership Information
Institutional Ownership Percentage	33.30%	36.63%	73.05%	97.41%	N/A
Insider Ownership Percentage	16.41%	N/A	27.40%	12.40%	N/A
Miscellaneous
Employees	253	75	51	114	73
Shares Outstanding	42.49 million	37.71 million	19.71 million	97.48 million	38.12 million
Next Earnings Date	3/4/2021 (Confirmed)	3/5/2021 (Estimated)	5/3/2021 (Estimated)	5/27/2021 (Estimated)	N/A
Optionable	Optionable	Not Optionable	Not Optionable	Optionable	Not Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources